How the President`s order can affect pharmaceutical advertising and promotion - read the text carefully and reject speculation

The first comments of the National Security and Defense Council and scenarios

Permitted and prohibited advertising of medicine (or back to the basics)

Alternatives to advertising of medicine, which are very similar to it, but is not it (information at the point of sale, information disseminated among health professionals, information at the request of consumers)

Flexible and comprehensive information in points-of-sale - where there are fine lines between advertising and such information, and what may be liable for, such as violations of advertising law

Dissemination of information on the Internet - when and why it becomes advertising or vice versa

The opinion of the AMCU on information on the Internet - what to consider in order not to receive fines

Information for POZ - legal requirements and practical features of dissemination (how to avoid "advertising consequences")

Red lines of the AMCU and the State Tax Service on the dissemination of information about medicine, including advertising and promotion

A short glossary of banned terms for advertising - what and how the AMCU does not like (real-life examples)

Comparative advertising - the current state of responsibility for distribution or how to compare the compared with the comparable

Technical rules for advertising from the State Tax Service - survival regulations